KAINOS Laboratories, Inc. (TYO:4556)

Market Cap	10.11B +92.0%
Revenue (ttm)	4.44B +8.5%
Net Income	82.76M -19.1%
EPS	18.58 -19.1%
Shares Out	4.45M
PE Ratio	122.31
Forward PE	n/a
Dividend	35.00 (1.54%)
Ex-Dividend Date	Mar 28, 2025

Volume	400
Average Volume	1,460
Open	2,273.00
Previous Close	2,273.00
Day's Range	2,273.00 - 2,273.00
52-Week Range	1,201.00 - 2,284.00
Beta	0.53
RSI	70.75
Earnings Date	May 15, 2026

About KAINOS Laboratories

KAINOS Laboratories, Inc. engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products in Japan. It is also involved in the development, manufacture, marketing, distribution, and import/export of physical and chemical measurement instruments, and medical supplies, as well as nutrition supplements, foodstuff, animal feed, and related products. The company provides various biochemical clinical testing reagents systems, such as Aqua-auto Kainos CRE-IV Tes...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1975
• Employees: 133
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4556

Financial Performance

In fiscal year 2010, KAINOS Laboratories's revenue was 4.22 billion, an increase of 17.25% compared to the previous year's 3.59 billion. Earnings were 101.44 million, a decrease of -39.52%.